BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10430221)

  • 1. Therapy for Kaposi's sarcoma: recent advances and experimental approaches.
    Yarchoan R
    J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S66-73. PubMed ID: 10430221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the treatment of AIDS-related Kaposi's sarcoma.
    Cattelan AM; Trevenzoli M; Aversa SM
    Am J Clin Dermatol; 2002; 3(7):451-62. PubMed ID: 12180893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging treatments for epidemic (AIDS-related) Kaposi's sarcoma.
    McGarvey ME; Tulpule A; Cai J; Zheng T; Masood R; Espina B; Arora N; Smith DL; Gill PS
    Curr Opin Oncol; 1998 Sep; 10(5):413-21. PubMed ID: 9800111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Kaposi's sarcoma in HIV-1 infected individuals with emphasis on resource poor settings.
    Dedicoat M; Vaithilingum M; Newton R
    Cochrane Database Syst Rev; 2003; (3):CD003256. PubMed ID: 12917957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group.
    Walmsley S; Northfelt DW; Melosky B; Conant M; Friedman-Kien AE; Wagner B
    J Acquir Immune Defic Syndr; 1999 Nov; 22(3):235-46. PubMed ID: 10770343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
    Dezube BJ
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma.
    Miles SA; Dezube BJ; Lee JY; Krown SE; Fletcher MA; Saville MW; Kaplan L; Groopman J; Scadden DT; Cooley T; Von Roenn J; Friedman-Kien A;
    AIDS; 2002 Feb; 16(3):421-9. PubMed ID: 11834954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of epidemic (AIDS-related) Kaposi's sarcoma.
    Jie C; Tulpule A; Zheng T; Masood R; Espina B; Gill PS
    Curr Opin Oncol; 1997 Sep; 9(5):433-9. PubMed ID: 9327221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma following allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia.
    de Medeiros BC; Rezuke WN; Ricci A; Tsongalis G; Shen PU; Bona RD; Feingold JM; Edwards RL; Tutschka PJ; Bilgrami S
    Acta Haematol; 2000; 104(2-3):115-8. PubMed ID: 11154986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New therapies for the treatment of AIDS-related Kaposi sarcoma.
    Dezube BJ
    Curr Opin Oncol; 2000 Sep; 12(5):445-9. PubMed ID: 10975552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations.
    Stebbing J; Wildfire A; Portsmouth S; Powles T; Thirlwell C; Hewitt P; Nelson M; Patterson S; Mandalia S; Gotch F; Gazzard BG; Bower M
    Ann Oncol; 2003 Nov; 14(11):1660-6. PubMed ID: 14581275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategies for epidemic Kaposi's sarcoma.
    Volm MD; von Roenn JH
    Curr Opin Oncol; 1995 Sep; 7(5):429-36. PubMed ID: 8541388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.
    Duvic M; Friedman-Kien AE; Looney DJ; Miles SA; Myskowski PL; Scadden DT; Von Roenn J; Galpin JE; Groopman J; Loewen G; Stevens V; Truglia JA; Yocum RC
    Arch Dermatol; 2000 Dec; 136(12):1461-9. PubMed ID: 11115156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of AIDS-related Kaposi's sarcoma during therapy with thalidomide.
    Solèr RA; Howard M; Brink NS; Gibb D; Tedder RS; Nadal D
    Clin Infect Dis; 1996 Sep; 23(3):501-3; discussion 504-5. PubMed ID: 8879772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma.
    Bodsworth NJ; Bloch M; Bower M; Donnell D; Yocum R;
    Am J Clin Dermatol; 2001; 2(2):77-87. PubMed ID: 11705307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Kaposi's sarcoma.
    Von Roenn JH; Cianfrocca M
    Cancer Treat Res; 2001; 104():127-48. PubMed ID: 11191125
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical aspects and management of AIDS-related Kaposi's sarcoma.
    Levine AM; Tulpule A
    Eur J Cancer; 2001 Jul; 37(10):1288-95. PubMed ID: 11423260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kaposi's sarcoma treated with topical alitretinoin].
    González de Arriba A; Pérez-Gala S; Goiriz-Valdés R; Ríos-Buceta L; García-Díez A
    Actas Dermosifiliogr; 2007; 98(1):50-3. PubMed ID: 17374335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alitretinoin (Panretin) gel 0.1%.
    Rhoads J
    J Assoc Nurses AIDS Care; 2001; 12(5):86-91. PubMed ID: 11565242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatments of AIDS-related Kaposi's sarcoma.
    Aversa SM; Cattelan AM; Salvagno L; Crivellari G; Banna G; Trevenzoli M; Chiarion-Sileni V; Monfardini S
    Crit Rev Oncol Hematol; 2005 Mar; 53(3):253-65. PubMed ID: 15718150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.